SUDBURY – Verv Technologies’ Board of Directors is pleased to announce the appointment of Martin (Marty) Gurbin as CEO. Marty brings with him a deep understanding of global healthcare, health innovation, emerging health technologies, and an international network from 20+ yrs. in healthcare and start-ups. Gurbin has assumed this position at an exciting time in [...]
Led by founder Jeff Sutton (pictured), Verv Technologies has raised $3.8 million from a British investor to continue developing its home blood testing kit. The system uses a drop of blood from a finger prick, a disposable test cartridge and a Bluetooth-enabled analyzer to transmit test results to a smartphone app in 15 minutes. The company operates [...]
Verv Technologies cashes up to advance its technology through the U.S. regulatory process. The CEO of a Sudbury medical technology company said it's about a year away from taking its transformative home blood-testing kit to the market. Jeff Sutton, one of the founders of Verv Technologies, expects their blood analyzer device, dubbed Vi, to be in [...]
Sudbury-based healthtech startup Verv has secured $3.8 million CAD in seed funding from United Kingdom vitro diagnostics company Randox Laboratories. Peter Fitzgerald, founder and managing director of Randox, will join Verv’s board of directors. Founded in 2012 by Jeff Sutton, Verv is developing an at-home blood testing kit named Vi. With a finger prick of [...]
Whether for those with chronic health conditions or those who are just curious, Verv Technologies’ home blood-testing device does more than check blood sugar, it aims to be a high-quality blood chemistry analyser to track everything from cholesterol to hormone levels. A Sudbury-based medical biotechnology company working at the Health Sciences North Research Institute (HSNRI) [...]
Investment from Randox helps fast-track Verv Technologies' home blood testing kit toward market Sudbury medical technology company, that’s looking to commercialize a home blood testing kit, has secured $3.8 million from its leading investor in the United Kingdom. Verv Technologies announced this week of the seed round funding from Randox Laboratories, a globally recognized biotechnology and [...]
A Sudbury-based medical technology company said Thursday it has secured $3.8 million in funding from global health leader Randox Laboratories of the U.K. In a release, Verv Technologies Ltd. said the seed money from Randox, an internationally recognized biotechnology and laboratory services leader, will help develop its blood chemistry analyser. “We are thrilled to have [...]
Sudbury, July 21, 2022: Verv Technologies Ltd (Verv) is proud to announce a $3.8M CAD seed round from internationally recognized biotechnology and laboratory services leader, Randox Laboratories, UK. Two out of three people want to be able to test their blood at home. Verv is focused on creating the first of its kind consumer-oriented, affordable, high-quality blood chemistry analyser [...]
On this week's episode, Mike and Steve welcome Victoria Coleman, Vice President of Business Development at Verv Technologies, a Sudbury-based med-tech startup. The guys chatted with Victoria about her career path from a clinician to an executive, the growing importance of telemedicine, and how Verv's disruptive technology, a home biochemistry lab, will change healthcare by [...]
Sudbury-based Verv Technologies has secured $140,000 from the National Research Council of Canada to help further development of its in-home blood-testing device, Vi. Sudbury med-tech company Verv Technologies has received $140,000 from the National Research Council of Canada (NRCC) to help in the development of its in-home blood-testing device, Vi. Announced on Oct. 29, the [...]
